Public Company News
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 10:08
3321
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 7, 2025 /PRNewswire/ -- From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) delivered an oral presentation o...
2025-12-08 10:00
1526
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2025-12-08 09:02
1650
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 08:15
2879
CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced today announced with great pleasure that its independently developed fully human BCMA-targeted CAR-T product, zevorcabtage...
2025-12-07 17:21
3408
All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
HONG KONG, Dec. 7, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL) for 2025, released byChina's National Healthcare Securi...
2025-12-07 14:18
2108
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2025-12-07 11:40
2496
SK hynix Honored with Two Major Titles at GSA Awards 2025
* Company named "Best Financially Managed Semiconductor Company (Achieving Greater than$1 Billion in Annual Sales)" and "Outstanding Asia-Pacific Semiconductor Company" simultaneously * Accelerates recovery from market downturn leveraging world-class HBM leadership; Global management performa...
2025-12-07 07:48
2316
Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of 'Neurophet AQUA AD'
* Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables monitoring of adverse effects associated with Alzheimer's disease treatments * Highlighted clinical cases that improved the safety of anti-amyloid therapy administration during an AI Theater session ...
2025-12-05 22:00
4727
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("the Company"), listed on Nasdaq, today announced its financial results for the six months endedSeptember 30, 2025, achieving substantial revenue increase and a meaningful improvement in gross profit following its ...
2025-12-05 21:45
5253
Marvion Inc. Signs Exclusive Client Referral MOU with STAR Warehouse Engineering Limited, Strengthening Warehouse Engineering, Logistics Capacity and Corporate Client Acquisition
HONG KONG, Dec. 5, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) today announced that it has entered into a12-month binding Memorandum of Understanding (MOU) with STAR Warehouse Engineering Limited ("STAR"). Under the agreement, STAR willexclusively and with priority refer its engineering clien...
2025-12-05 21:18
4780
China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles
WUHAN, China, Dec. 5, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier inChina, today announced that its subsidiary, Hyoseong ( Wuhan) Motion Mechatronics System Co. Ltd., has entered the final co...
2025-12-05 19:00
4032
TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet
NANJING, China and GAITHERSBURG, Md., Dec. 4, 2025 /PRNewswire/ -- TransThera Sciences Inc. ("TransThera") announced the publication of clinical results from a US-based Phase 2 trial evaluating tinengotinib in patients with Cholangiocarcinoma (CCA) on The Lancet Gastroenterology and Hepatology (I...
2025-12-05 12:31
2087
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
SAN FRANCISCO and SUZHOU, China, Dec. 4, 2025 /PRNewswire/ -- Innovent Biologics (HKEX: 01801) today announced that the global strategic collaboration with Takeda (TSE: 4502, NYSE: TAK) has closed and become effective following the satisfaction of all closing conditions. The collaboration, initia...
2025-12-05 07:38
1931
PINTEC TO HOLD EXTRAORDINARY GENERAL MEETING ON JANUARY 8, 2026
BEIJING, Dec. 4, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (NASDAQ: PT) ("Pintec" or the "Company"), a technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that the Company will hold its extraordinary general ...
2025-12-05 05:00
3676
WiMi Studies Hybrid Quantum-Classical Learning Architecture for Multi-Class Image Classification
BEIJING, Dec. 4, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), is a leading global Hologram Augmented Reality ("AR") Technology provider. On the basis of in-depth research on quantum convolutional neural networks (QCNN), it proposed a new type of hybrid ...
2025-12-05 01:15
4728
300MW/1200MWh Energy Storage Station Successfully Commissioned -- Powered by SINEXCEL's 1725kW PCS
SHENZHEN, China, Dec. 4, 2025 /PRNewswire/ -- The first phase (300 MW/1200 MWh) ofChina's largest electrochemical energy storage station, powered by SINEXCEL's 1725kW utility-scale Power Conversion System (PCS), has been successfully commissioned. This milestone marks a critical step toward full-...
2025-12-04 23:00
2749
Cheche Group Partners with FAW Bestune to Launch Industry-First Fully Digital One-Stop Vehicle Delivery Service
BEIJING, Dec. 4, 2025 /PRNewswire/ -- Cheche Group Inc.
2025-12-04 21:30
4577
Massimo Group Announces Formation of AI Robotics Division, Expanding Into Global Automation and Smart-Systems Markets
GARLAND, Texas, Dec. 4, 2025 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) today announced the establishment of Massimo AI Technology, Inc, a 100% subsidiary of Massimo Group, marking a measured and strategic step into the expanding global markets for industrial and service robotics. This initiati...
2025-12-04 21:25
4152
Huya Wins Outstanding Esports Platform in 2025 Forbes China Esports 30 Selection
GUANGZHOU, China, Dec. 4, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today announced it has been named an Outstanding Esports Platform in the 2025 Forbes China Esports 30 Selection, a prestigious recognition ...
2025-12-04 19:30
2075
Week's Top Stories
Most Reposted
Tetra Pak Opens Product Development Centre in Thailand, Unlocking A World of Possibilities for Food and Beverage Innovators Across Asia Pacific
[Picked up by 316 media titles]
2026-03-27 11:15
Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 312 media titles]
2026-03-24 14:00Indonesia's P2P Lending Grows 25%, JULO Strengthens Credit Quality
[Picked up by 300 media titles]
2026-03-26 18:18
ART CENTRAL COMMENCES DISCOVERY-LED ELEVENTH EDITION
[Picked up by 279 media titles]
2026-03-25 16:51
Noah Reports Q4 and Full Year 2025 Earnings: Structural Transformation Driving Significant Improvement in Profitability as AI Integration Drives Operational Efficiency
[Picked up by 275 media titles]
2026-03-25 21:58